iTeos Therapeutics, Inc. (ITOS)

NASDAQ: ITOS · IEX Real-Time Price · USD

14.44

-0.57 (-3.80%)

At close: Jul 2, 2024, 4:00 PM

14.72

+0.28 (1.94%)

After-hours: Jul 2, 2024, 4:06 PM EDT

iTeos Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	12.6	267.63	344.78	0	0	Upgrade
Revenue Growth (YoY)	-95.29%	-22.38%	-	-	-	Upgrade
Gross Profit	12.6	267.63	344.78	0	0	Upgrade
Selling, General & Admin	50.4	43.95	40.51	15.34	8.84	Upgrade
Research & Development	113.3	97.36	59.37	29.9	19.21	Upgrade
Operating Expenses	163.7	141.31	99.87	45.24	28.05	Upgrade
Operating Income	-151.1	126.32	244.9	-45.24	-28.05	Upgrade
Other Expense / Income	-42.07	-22.41	-11.56	-7.15	-5.71	Upgrade
Pretax Income	-109.03	148.74	256.46	-38.09	-22.34	Upgrade
Income Tax	3.61	52.08	41.94	-0.06	0.12	Upgrade
Net Income	-112.64	96.65	214.52	-38.03	-22.45	Upgrade
Preferred Dividends	0	0	0	5.37	4.08	Upgrade
Net Income Common	-112.64	96.65	214.52	-43.4	-26.54	Upgrade
Net Income Growth	-	-54.95%	-	-	-	Upgrade
Shares Outstanding (Basic)	36	36	35	15	0	Upgrade
Shares Outstanding (Diluted)	36	38	38	15	0	Upgrade
Shares Change	-5.30%	-0.02%	150.49%	7336.29%	-67.03%	Upgrade
EPS (Basic)	-3.15	2.72	6.10	-2.88	-130.85	Upgrade
EPS (Diluted)	-3.15	2.56	5.68	-2.88	-130.85	Upgrade
EPS Growth	-	-54.93%	-	-	-	Upgrade
Free Cash Flow	-106.72	-112.13	511.96	-25.53	-23.87	Upgrade
Free Cash Flow Per Share	-2.98	-3.15	14.55	-1.69	-117.69	Upgrade
Gross Margin	100.00%	100.00%	100.00%	-	-	Upgrade
Operating Margin	-1199.69%	47.20%	71.03%	-	-	Upgrade
Profit Margin	-894.34%	36.11%	62.22%	-	-	Upgrade
Free Cash Flow Margin	-847.34%	-41.90%	148.49%	-	-	Upgrade
Effective Tax Rate	-	35.02%	16.35%	-	-	Upgrade
EBITDA	-108.13	149.54	257.07	-37.56	-21.72	Upgrade
EBITDA Margin	-858.53%	55.88%	74.56%	-	-	Upgrade
Depreciation & Amortization	0.9	0.8	0.6	0.54	0.61	Upgrade
EBIT	-109.03	148.74	256.46	-38.09	-22.34	Upgrade
EBIT Margin	-865.66%	55.58%	74.39%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).